After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Award
Calculated transaction value
$0

Miller Aine SVP, Dev & Head Of Ire Office

Transaction date Jun 19, 2026
Public filing date Jun 23, 2026
Filing lag Filed 4 days later

TBPH daily price context

Close on/before transaction
$16.58 Jun 18, 2026
First close after public filing
$17.27 Jun 24, 2026
30-day return after filing
-2.37% Through Jul 23, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Ordinary Shares
Quantity / price
18,750 shares @ $0
SEC ownership
Direct
Transaction code
A
Form
4
Filing identifier
0002012524-26-000006
Filing cohort

Transactions in this filing

Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Theravance Biopharma, Inc. TBPH Current Award Jun 19, 2026 $0